Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Nocturnal Breathing at Altitude
NCT05037032Phase 4Completed
- Sponsor
- VA Loma Linda Healthcare System
- Start
- Aug 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in periodic breathing, central sleep apnea (CSA), sponsored by VA Loma Linda Healthcare System. Started Aug 2021; status: completed.
02
Drugs
naltrexone
03
Conditions
periodic breathingcentral sleep apnea (CSA)
Beyond the preview
Go deeper on NCT05037032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05037032.